These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 11592832
1. Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. Kamata Y, Okuyama T, Kosuga M, O'hira A, Kanaji A, Sasaki K, Yamada M, Azuma N. Mol Ther; 2001 Oct; 4(4):307-12. PubMed ID: 11592832 [Abstract] [Full Text] [Related]
2. Long-term normalization in the central nervous system, ocular manifestations, and skeletal deformities by a single systemic adenovirus injection into neonatal mice with mucopolysaccharidosis VII. Kamata Y, Tanabe A, Kanaji A, Kosuga M, Fukuhara Y, Li XK, Suzuki S, Yamada M, Azuma N, Okuyama T. Gene Ther; 2003 Mar; 10(5):406-14. PubMed ID: 12601395 [Abstract] [Full Text] [Related]
3. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice. Kosuga M, Sasaki K, Tanabe A, Li XK, Okawa H, Ogino I, Okuda O, Arai H, Sakuragawa N, Kamata Y, Azuma N, Suzuki S, Yamada M, Okuyama T. Mol Ther; 2001 Feb; 3(2):139-48. PubMed ID: 11237670 [Abstract] [Full Text] [Related]
4. Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection. Derksen TA, Sauter SL, Davidson BL. J Gene Med; 2002 Feb; 4(5):463-9. PubMed ID: 12221638 [Abstract] [Full Text] [Related]
5. Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression. Kosuga M, Takahashi S, Sasaki K, Li XK, Fujino M, Hamada H, Suzuki S, Yamada M, Matsuo N, Okuyama T. Mol Ther; 2000 May; 1(5 Pt 1):406-13. PubMed ID: 10933961 [Abstract] [Full Text] [Related]
6. Widespread distribution of adenovirus-transduced monkey amniotic epithelial cells after local intracerebral injection: implication for cell-mediated therapy for lysosome storage disorders. Kosuga M, Takahashi S, Tanabe A, Fujino M, Li XK, Suzuki S, Yamada M, Kakishita K, Ono F, Sakuragawa N, Okuyama T. Cell Transplant; 2001 May; 10(4-5):435-9. PubMed ID: 11549068 [Abstract] [Full Text] [Related]
10. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Stein CS, Kang Y, Sauter SL, Townsend K, Staber P, Derksen TA, Martins I, Qian J, Davidson BL, McCray PB. Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898 [Abstract] [Full Text] [Related]
11. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer. Ghodsi A, Stein C, Derksen T, Martins I, Anderson RD, Davidson BL. Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195 [Abstract] [Full Text] [Related]
18. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors. Bosch A, Perret E, Desmaris N, Heard JM. Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913 [Abstract] [Full Text] [Related]